September 29, 2022

MS is a chronic inflammatory disease of the CNS, the pathogenesis associated with miRNAs. miRNAs also serve as effective therapeutic targets in MS patients. Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS). MicroRNAs (miRNAs) are complex endogenous biomolecules that function as gene super-regulators. This review was published in...

Patients with MS demonstrate an accumulation of disabilities, which can be delayed by applying disease-modifying therapies. Multiple sclerosis (MS) patients acquire disability via progression independent of relapse activity (PIRA) or relapse-associated worsening (RAW). This study was published in the journal BRAIN, and discusses the contribution of MS relapses to the worsening of disability through the...

A recent clinical trial indicates that self-acupressure is an effective non-pharmaceutical treatment for reducing fatigue in multiple sclerosis patients. Multiple Sclerosis (MS) is a neurological illness that causes inflammation, neurological impairment, and neurodegeneration in the central nervous system. The disorder may potentially cause irreparable damage to the nerves. One of the major symptoms of MS...